COAG
Hemab Therapeutics Holdings, Inc. Common Stock
There isn't enough reported data to score COAG yet.
COAG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate COAG's fundamentals.
COAG PE Valuation
COAG has no meaningful PE right now: it lost money over the past year.
COAG Forward outlook
There aren't enough analyst estimates for COAG to show an outlook.
COAG Earnings Per Share
COAG Quarterly Revenue
COAG Free Cash Flow
COAG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +55% | +16.6M shares |
COAG Net Leverage
COAG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
COAG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.8 | Neutral |
| Stochastic | 56.7 | Neutral |
COAG's weekly RSI is 40 (neutral) and its Stochastic is 57 (neutral).
COAG PE vs Healthcare Sector
COAG has no meaningful PE right now: it lost money over the past year.
COAG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.5 | 8% above |
| 20 week MA | $41.4 | 4.9% below |
COAG has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 4.9% below its 20-week average.
COAG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $34.0 | $39.4 | +16% |
It's up 16% so far in 2026.